UY27331A1 - HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS - Google Patents

HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS

Info

Publication number
UY27331A1
UY27331A1 UY27331A UY27331A UY27331A1 UY 27331 A1 UY27331 A1 UY 27331A1 UY 27331 A UY27331 A UY 27331A UY 27331 A UY27331 A UY 27331A UY 27331 A1 UY27331 A1 UY 27331A1
Authority
UY
Uruguay
Prior art keywords
hiv protease
pharmaceutical
synthesis
compositions
contain
Prior art date
Application number
UY27331A
Other languages
Spanish (es)
Inventor
Therese N Alexander
Mark R Barvian
Gary L Bolton
Frederick E Boyer Jr
Benjamin J Burke
Tod P Holler
Tanya M Jewell
Vara Prasad Venkata Na Josyula
David J Kucera
Maria A Linton
Jeff J Machak
Sean T Murphy
Siegfried H Reich
Donald J Skalitzky
John H Tatlock
Michael D Varney
Scott C Virgil
Stephen E Webber
Stephen T Worland
Michael Menlick
Stacie S Canan-Koch
Lennert J Mitchell Jr
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Priority to UY27331A priority Critical patent/UY27331A1/en
Publication of UY27331A1 publication Critical patent/UY27331A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compuestos de fórmula: donde las variables de la fórmula que se definió en el presente inhiben o bloquean favorablemente la actividad biológica de la proteasa de VIH. Estos compuestos, así como las composiciones farmacéuticas que los contienen, son útiles para el tratamiento de pacientes o portadores infectados con el virus VIH. También se describen productos intermedios y métodos sintéticos para la preparación de dichos compuestos.Formula compounds: where the variables of the formula defined herein inhibit or favorably block the biological activity of the HIV protease. These compounds, as well as the pharmaceutical compositions containing them, are useful for the treatment of patients or carriers infected with the HIV virus. Intermediates and synthetic methods for the preparation of said compounds are also described.

UY27331A 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS UY27331A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27331A UY27331A1 (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27331A UY27331A1 (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS

Publications (1)

Publication Number Publication Date
UY27331A1 true UY27331A1 (en) 2003-02-28

Family

ID=38812657

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27331A UY27331A1 (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS

Country Status (1)

Country Link
UY (1) UY27331A1 (en)

Similar Documents

Publication Publication Date Title
PA8547501A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS
CO2022018811A2 (en) Kras g12c protein inhibitors and their uses
ES2181725T3 (en) HIV PROTEASA INHIBITORS.
PA8583401A1 (en) NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
UY27882A1 (en) CHEMICAL COMPOUNDS
PA8547701A1 (en) NUCLEOSIDS 4 SUBSTITUTED.
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
ECSP055801A (en) BENZOFURANIC COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROFILAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
UY28691A1 (en) DERIVATIVES OF DIFENILAZETIDONA
PA8582701A1 (en) NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
HN2002000067A (en) INHIBITORS OF THE RHO - QUINASA.
ECSP077235A (en) BENZAMIDS REPLACED BY TRIFLUORO-METHYL AS QUINASE INHIBITORS
CO6531452A2 (en) SUBSTITUTED PIPERIDINS THAT INCREASE THE ACTIVITY OF P53 AND ITS USES
UY28695A1 (en) DERIVATIVES OF DIFENILAZETIDONA
PA8583101A1 (en) NEW COMPOUNDS OF ISOTIAZOL AND ISOXAZOL AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
DOP2000000108A (en) ANTI-CORPOVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR SYNTHESIS
DOP2006000017A (en) PIRAZOLOPIRIDINAS AND SALTS OF THE SAME, A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, A METHOD FOR PREPARING THEM AND THEIR USE
UY27851A1 (en) DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE.
ECSP045477A (en) AMIDES COMPOUNDS OF ACID3-AMINO-TIENO [2,3-b] PIRIDINO-2-CARBOXYL REPLACED AND PROCEDURES TO PREPARE THEM AND THEIR USES.
UY39181A (en) COMPOUNDS AND COMPOSITIONS FOR INHIBITING HIF2a ACTIVITY AND THEIR METHODS OF USE
CU20200100A7 (en) HYDROTIENOPYRIDINE 3-CYANE N-SUBSTITUTE COMPOUNDS USEFUL TO PREVENT AND TREAT VIRAL INFECTIONS, ESPECIALLY DENGUE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY26666A1 (en) ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR THEIR SYNTHESIS
UY27331A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS
UY26307A1 (en) EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES
UY27330A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130107